Neonatal Abstinence Syndrome Problems From Opioids in Pregnancy Has Soared In Recent Years

The number of infants born with opioid withdrawal symptoms, known as neonatal abstinence syndrome, has increased dramatically in recent years, with the costs associated with the treatment nearly doubling between 2012 and 2016.

The nationwide opioid abuse crisis in the United States over the past decade has not only resulted in overdoses and other injuries for users of the powerful painkillers, but have also had a dramatic effect on a number of children exposed to the opioids before they were born.

Neonatal abstinence syndrome (NAS) is the name of a condition occurring among infants exposed to opioids during pregnancy, which can result from normal use of the medications, or opioid abuse by the pregnant mother, causing the infants to experience severe withdrawal symptoms.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

In a study published this month in the medical journal JAMA Pediatrics, researchers indicate that the rates of NAS in the United States have increased from about 1.5 per 1,000 hospital births in 2004 to 8 per 1,000 hospital births in 2014.

The findings also indicate that hospital costs associated with treating neonatal abstinence syndrome problems from opioids in pregnancy has rose from $316 million in 2012 to $572.7 million in 2016, highlighting the increasing opioid epidemic over the four year period.

Infants with NAS spent an average of 16 days in the hospital at an average of $22,550 per day, and a similar CDC study published in 2016 warned the number of infants with opioid withdrawal syndrome had increased more than 300%.

Opioid use during pregnancy is linked to serious consequences for both mother and child. It can cause maternal death and increases the risk of a mother overdosing. It can also increase the risk of preterm birth, lead to breathing problems and feeding problems, cause birth defects, cause developmental problems to the child later, and impair cognition.

An estimated 10.3 million Americans ages 12 and older misused opioids in 2018 and the crisis only seems to continue to worsen.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted today)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted yesterday)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted yesterday)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.